Update on glasdegib in acute myeloid leukemia – broadening horizons of Hedgehog pathway inhibitors
By: Cyril Fersing and Fanny Mathias
Authors
Cyril Fersing
cyril.fersing@icm.unicancer.fr
University of Montpellier, Montpellier Cancer Institute (ICM), Montpellier, France
Institut des Biomolécules Max Mousseron UMR 5247, CNRS, Université de Montpellier ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, France
Fanny Mathias
Aix Marseille Univ, Pharmacy Department Hôpital Nord, Assistance Publique Hôpitaux de Marseille, Marseille, France
Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire Faculté de Pharmacie, France
Language: English
Page range: 9 - 34
Accepted on: Jan 26, 2021
Published on: Aug 30, 2021
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2021 Cyril Fersing, Fanny Mathias, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.